IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes

Authors

Institutions

Publication Details

Journal
Circulation
Published
2025-12-18
DOI
https://doi.org/10.1161/circulationaha.125.074041
Citations
1
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
1.29
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes

Jai Chand Patel, Jeremy Robbins, Michael Frenneaux, Adrienne. G. Siu et al.
1 citations
Circulation
Diabetes Treatment and Management
1.29
article

IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes

Jai Chand Patel, Jeremy Robbins, Michael Frenneaux, Adrienne. G. Siu, Sarah Birkhoelzer, Damian J. Tyler, Jack J. Miller, Moritz Hundertmark, Violet Matthews, Arash Yavari, John A. Henry, Oliver J. Rider, Ferenc E. Mózes, Paul Chamberlin, Rizwan Sarwar, Robert E. Gerszten, Clara Portwood, Prashant Rao, James T. Grist, Stefan Neubauer, Hakim‐Moulay Dehbi, Andrew Lewis, Ladislav Valkovič, Xu Shi, Shuning Zheng
article en
1 citations

Abstract

No abstract available for this paper.
CirculationVol. 153(8)
Beth Israel Deaconess Medical Center (US), Aarhus University (DK), University Hospital of Bern (CH), Aarhus University Hospital (DK), John Radcliffe Hospital (GB), University of Oxford (GB), MRC Clinical Trials Unit at UCL (GB), Institute of Measurement Science of the Slovak Academy of Sciences (SK), NIHR Imperial Biomedical Research Centre (GB), Alexion Pharmaceuticals (United States) (US), Cancer Research UK Clinical Trials Unit (GB), Pediatrics and Genetics (US), Oxford University Hospitals NHS Trust (GB), Comprehensive Clinical Trials (US), University College London (GB), Imperial College London (GB), University of Birmingham (GB)
Openalex Percentile: Top 13%
Diabetes Treatment and Management
1.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.